Short report: antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-s-transferase, a phase ii detoxification enzyme

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 764-768

  Awasthi, Satish K ^a,b,c   Mishra, Nidhi ^a,b   Dixit, Sandeep Kumar ^a,b   Singh, Alka ^a,b   Yadav, Marshleen ^a,b   Yadav, Sudhanshu S ^a,b   Rathaur, Sushma ^a,b  

^a UNIVERSITY OF DELHI   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c Chemical Biology Laboratory   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 BENZOTRIAZOL 1 YL PHENYL) 3 (4 METHOXYPHENYL)PROP 2 EN 1 ONE; 3 (4 CHLOROPHENYL) 1 (4 PIPERIDIN 1 YL PHENYL)PROP 2 EN 1 ONE; 3 (4 METHOXYPHENYL) 1 (4 PYRROLIDIN 1 YL PHENYL)PROP 2 EN 1 ONE; ANTIFILARIAL AGENT; CHALCONE DERIVATIVE; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PROPANE;

ANIMAL EXPERIMENT; ANTHELMINTIC ACTIVITY; ANTIFILARIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; IN VITRO STUDY; NONHUMAN; PARASITE VIABILITY; PROTEIN DEPLETION; SETARIA CERVI; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; SETARIA;

SETARIA CERVI;

ANIMALS; CHALCONES; FEMALE; FILARICIDES; GLUTATHIONE TRANSFERASE; MOLECULAR STRUCTURE; PROPANE; SETARIA NEMATODE;

EID: 66149110763     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.764     Document Type: Article

References (34)

1. Reed DJ, 1995. Molecular and Cellular Mechanisms of Toxicity. Boca Raton, FL: CRC Press.
2. Ottesen EA, Vijayaseksran V, Kumaraswami V, Pillai SVP, Sadanandam A, Sheila F, Prabhakar R, Tripathy SP, 1990. A controlled trial of ivermectin and diethylcarbamazine in lymphatc filariasis. N Engl J Med 322:1113-1117.
3. Nathan ST, Methew N, Kalyanasundaram M, Balaraman K, 2005. Structure of glutathione S-transferase of the filarial parasite Wuchereria bancrofti: a target for drug development against adult worm. J Mol Model 11:194-199.
4. Bennett JL, Williams JF, Dave V, 1988. Pharmacology of ivermec-tin. Parasitol Today 4: 226-228.
5. Ginger CD, 1986. Advances in filarial chemotherapy and screen-ing. Parasitol Today 2: 38-40.
6. Loiseau PM, 1993. In vitro antifilarial evaluation of phenoxycyclo-hexane derivatives. Ann Trap Med Parasitol 87: 469-476.
7. Singh SN, Bhatnagar S, Fatma N, Chauhan PMS, Chatterjee RK, 1997. Antifilarial activity of a synthetic marine alkaloid aplysinospin. Trop Med Int Health 2: 535-543.
8. Townsend LB, Wise DS, 1990. The synthesis and chemistry of cer-tain antihelmintic benzimidazole. Parasitol Today 6: 107-112.
9. Mannervik B, Danielson UH, 1988. Glutathione transferases, structure and catalytic activity. CRC Crit Rev Biochem 23: 283-337.
10. Gomez FJS, Gayarre J, Avellano MI, Sala DP, 2007. Direct evi-dence for the covalent modification of glutathione S-transferase Pf-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. Arch Biochem Biophys 457: 150-159.
11. Ibarraa CMP, Grillob ML, Belloc M, Nucettellic TK, Atkinsa Bammlerd WM, 2003. Exploration of in vitro pro-drug activa-tion and futile cycling by glutathione S-transferases: thiol ester hydrolysis and inhibitor maturation. Arch Biochem Biophys 414:303-311.
12. Nielsen SF, Larsen M, Bosen T, Schonning K, Kromann H, 2005. Cationic chalcone antibiotics, design, synthesis, and mechanism of action. J Med Chem 48:2667-2677.
13. Mishra N, Arora P, Kumar B, Mishra LC, Bhattacharya A, Awasthi SK, Bhasin VK, 2008. Synthesis of novel susbtituted 1, 3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur J Med Chem 43:1530-1535.
14. Awasthi SK, Mishra N, Kumar B, Sharma M, Mishra LC, Bhattacharya A, Bhasin VK, Potent antimalarial activity of newly synthesized substituted chalcone analogs in vitro. Med Chem Res. DOI: 10.1007/s00044-008-9137-9.
15. Robinson PT, Hubbard RB IV. Ehlers TJ, Arbiser JL, Goldsmith DJ, Bowen PJ, 2005. Synthesis and biological evaluation of aro-matic enones related to curcumin. Bioorg Med Chem 13: 4007-4013.
16. Vaya J, Belinky PA, Aviram M, 1997. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxi-dative capacity toward LDL oxidation. Free Radic Biol Med 23: 302-313.
17. Khatib S, Nerya O, Musa R, Shmuel M, Tamir S, Vaya J, 2005. Chalcones as potent tyrosinase inhibitors: the importance of a 2, 4-substituted resorcinol moiety. Bioorg Med Chem 13: 433-441.
18. Chen M, TheanderTG, Christensen BS, Hviid L, Zhai L, Kharazmi A, 1994. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother 38:1470-1475.
19. Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN, Davidson E, Kurzban G, Miller RE, Nuzum EO, Rosenthal PJ, McKerrow JH, 1995. In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 38: 5031-5037.
20. Gupta S, Rathaur S, 2005. Filarial glutathione S-transferase: its induction by xenobiotics and potential as drug target. Acta Biochim Pol 52:493-500.
21. Gupta S, Singh A, Yadav M, Singh K, Rathaur S, 2007. MALDI mass sequencing and characterization of filarial glutathione-s-transferase. Biochem Biophys Res Commun 356: 381-385.
22. Bradford MM, 1976. A rapid and sensitive method for the quanti-tation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
23. Mosmann TR, Coffman RL, 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
24. Habig WH, Pabst MJ, Jakoby WB, 1974. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
25. Ellman GL, 1959. Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77.
26. Jaiswal AK, 2004. Nrf2 signalling in activation of gene expression, free radical coordinated. Biol Med (Paris) 36:1199-1207.
27. Liu YC, Hsieh CW, Wu CC, Wung BS, 2007. Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endog-enous electrophile. Life Sci 80:1420-1430.
28. Huang J, Tan PH, Tan BK, Bay BH, 2004. GST-pi expression cor-relates with oxidative stress and apoptosis in breast cancer. Oncol Rep 12: 921-925.
29. Forkert PG, Costa DD, Mestrah ME, 1999. Expression and induc-ibility of Alpha, Pi and Mu glutathione-S-transferase protein and mRNA in murine lung. Am J Respir Cell Mol Biol 20: 143-152.
30. Nguyen T, Yang CS, Pickett CB, 2004. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37: 433-441.
31. Kawalek JC, Rew RS, Heavner J, 1984. Glutathione S-transferase a possible drug metabolizing enzyme in Haemouchus contoras: comparative activity of cambendazole resistant and susceptible strain. Int J Parasitol 14:173-175.
32. Brophy PM, Campbell AM, van Eldik AJ, Teesdale-Spittle PH, Liebau E, Wang MF, 2000. β-Carbonyl substituted glutathione conjugates as inhibitors of O. volvulus GST2. Bioorg Med Chem Lett 10: 979-981.
33. Brophy PM, Barrett J, 1990. Glutathione transferase in helminths. Parasitol 100: 345-349.
34. Rathaur S, Yadav M, Gupta S, Anandharaman V, Reddy MVR, 2008. Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine 26: 4094-4100.